chr22-17181809-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001282225.2(ADA2):​c.1442+11T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.308 in 1,607,306 control chromosomes in the GnomAD database, including 80,978 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6310 hom., cov: 33)
Exomes 𝑓: 0.31 ( 74668 hom. )

Consequence

ADA2
NM_001282225.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.00200

Publications

5 publications found
Variant links:
Genes affected
ADA2 (HGNC:1839): (adenosine deaminase 2) This gene encodes a member of a subfamily of the adenosine deaminase protein family. The encoded protein is one of two adenosine deaminases found in humans, which regulate levels of the signaling molecule, adenosine. The encoded protein is secreted from monocytes undergoing differentiation and may regulate cell proliferation and differentiation. This gene may be responsible for some of the phenotypic features associated with cat eye syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
ADA2 Gene-Disease associations (from GenCC):
  • deficiency of adenosine deaminase 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • vasculitis due to ADA2 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • polyarteritis nodosa
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • Sneddon syndrome
    Inheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • Diamond-Blackfan anemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 22-17181809-A-G is Benign according to our data. Variant chr22-17181809-A-G is described in ClinVar as Benign. ClinVar VariationId is 402526.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.335 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADA2NM_001282225.2 linkc.1442+11T>C intron_variant Intron 9 of 9 ENST00000399837.8 NP_001269154.1 Q9NZK5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADA2ENST00000399837.8 linkc.1442+11T>C intron_variant Intron 9 of 9 1 NM_001282225.2 ENSP00000382731.2 Q9NZK5-1

Frequencies

GnomAD3 genomes
AF:
0.277
AC:
42048
AN:
152032
Hom.:
6312
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.223
Gnomad AMI
AF:
0.226
Gnomad AMR
AF:
0.215
Gnomad ASJ
AF:
0.278
Gnomad EAS
AF:
0.0511
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.335
Gnomad MID
AF:
0.303
Gnomad NFE
AF:
0.339
Gnomad OTH
AF:
0.302
GnomAD2 exomes
AF:
0.256
AC:
64054
AN:
250578
AF XY:
0.258
show subpopulations
Gnomad AFR exome
AF:
0.217
Gnomad AMR exome
AF:
0.151
Gnomad ASJ exome
AF:
0.284
Gnomad EAS exome
AF:
0.0474
Gnomad FIN exome
AF:
0.324
Gnomad NFE exome
AF:
0.334
Gnomad OTH exome
AF:
0.271
GnomAD4 exome
AF:
0.311
AC:
453108
AN:
1455156
Hom.:
74668
Cov.:
31
AF XY:
0.309
AC XY:
223535
AN XY:
724322
show subpopulations
African (AFR)
AF:
0.213
AC:
7103
AN:
33364
American (AMR)
AF:
0.158
AC:
7049
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.284
AC:
7390
AN:
26042
East Asian (EAS)
AF:
0.0516
AC:
2050
AN:
39696
South Asian (SAS)
AF:
0.172
AC:
14849
AN:
86082
European-Finnish (FIN)
AF:
0.320
AC:
17058
AN:
53384
Middle Eastern (MID)
AF:
0.316
AC:
1548
AN:
4896
European-Non Finnish (NFE)
AF:
0.342
AC:
378338
AN:
1106930
Other (OTH)
AF:
0.295
AC:
17723
AN:
60084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
13528
27056
40585
54113
67641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11892
23784
35676
47568
59460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.276
AC:
42052
AN:
152150
Hom.:
6310
Cov.:
33
AF XY:
0.270
AC XY:
20094
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.223
AC:
9253
AN:
41542
American (AMR)
AF:
0.214
AC:
3280
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.278
AC:
965
AN:
3468
East Asian (EAS)
AF:
0.0513
AC:
265
AN:
5170
South Asian (SAS)
AF:
0.164
AC:
790
AN:
4826
European-Finnish (FIN)
AF:
0.335
AC:
3546
AN:
10596
Middle Eastern (MID)
AF:
0.291
AC:
85
AN:
292
European-Non Finnish (NFE)
AF:
0.339
AC:
23031
AN:
67936
Other (OTH)
AF:
0.298
AC:
631
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1528
3056
4585
6113
7641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
416
832
1248
1664
2080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.303
Hom.:
3517
Bravo
AF:
0.264
Asia WGS
AF:
0.113
AC:
391
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 33% of patients studied by a panel of primary immunodeficiencies. Number of patients: 32. Only high quality variants are reported. -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
May 10, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Vasculitis due to ADA2 deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.15
DANN
Benign
0.63
PhyloP100
0.0020
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58754958; hg19: chr22-17662699; COSMIC: COSV52831802; COSMIC: COSV52831802; API